NS

Narendra Sarekhsingh Kumar

Director DIN 05160740
DIN 05160740 First appointment Mar 2012
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Mar 2012
Shareholding value β€’β€’β€’β€’ Premium profile

About Narendra Sarekhsingh Kumar

Data last updated:

Narendra Sarekhsingh Kumar was a Director at Imedica Diagnostic Solutions Private Limited (from 2012) and Director at Aon Biotech Private Limited (from 2013).

DIN 05160740
First Appointment 22 Mar 2012
Oldest Company Age 14 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director22 Mar 20122012Strike Off
Aon Biotech Private Limited U24297DL2013PTC250733
Director15 Apr 20132013Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Imedica Diagnostic Solutions Private Limited
Aon Biotech Private Limited
Premium access

Shareholding and investment profile for Narendra Sarekhsingh Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Narendra Sarekhsingh Kumar

Narendra Sarekhsingh Kumar was first appointed on 22 Mar 2012 as Director at Imedica Diagnostic Solutions Private Limited. The most recent appointment on record is 15 Apr 2013 at Aon Biotech Private Limited.

Narendra Sarekhsingh Kumar held 2 earlier board appointments: Imedica Diagnostic Solutions Private Limited (Director, from 22 Mar 2012); Aon Biotech Private Limited (Director, from 15 Apr 2013).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available